Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for August 2010
August 2, 2010
- Allergan Reports Second Quarter 2010 Operating Results
- Allergan 2Q Net Income Rises 36 Percent
- FDA: Stem Cell Trial Can Proceed
- Pharmalive.Com Releases Annual Top 500 Prescription Medicines Special Report Analyzing Product Performance & Company Strategy
- Nupathe Expected To Go Public This Week
August 3, 2010
- Movetis receives a tender offer from Shire of ?19 cash per share for all outstanding shares and warrants
- Pfizer Reports Second-Quarter 2010 Results
- ArQule and Daiichi Sankyo Move Forward with Phase 3 Clinical Trial Plan for ARQ 197 in Non-Small Cell Lung Cancer
- Shire Proposes to Expand Specialist Gastrointestinal Portfolio
- Continua Health Alliance Commends the FCC and FDA for Working to Streamline the Wireless Medical Technology Review Process
- Sanofi Shares Drop On Report Of $18B Genzyme Bid
- FTC Appears To Be Winning A Battle With Generic-Drug Makers
- Senate Introduces The Drug Safety And Accountability Act Of 2010 And Rxp Releases Drug Safety Poll Findings
- Sanofi Offers to Buy Genzyme for $18.4 Billion
August 4, 2010
- GlaxoSmithKline in Deal with Muscle Drug Maker
- Shire Delivers Excellent Q2 Performance With Total Revenues Up 35%. Full Year Earnings Expectations Raised
- Teva Receives European Commission Approval for ratiopharm Acquisition
- Depomed Says Pfizer Has Not Disputed Application
- NicOx to Close US Headquarters
August 5, 2010
- FDA Posts Letters to Novartis and AstraZeneca
- Turnover and Profit Expectations Fulfilled for First half-year Results / New Growth Expected from Innovative Medicines
- Interim Financial Report for the Period 1 January 2010 to 30 June 2010 (5 August 2010)
- Watson Q2 Net Revenue Climbs 29 Percent to $875 Million
- Horizon Pharma Files For IPO Worth Up To $86.3 Million
- Millipore Corporation Reminds Holders of Its 3.75% Convertible Senior Notes That Make-Whole Conversion Period Expires August 25, 2010
August 6, 2010
- GenVec Announces New Agreement with Global Pharmaceutical Company
- Alliance for a Stronger FDA Hails Waxman-Harkin Letter Supporting Higher Funding for FDA
- Law Restricting Prescription Info Access Upheld
- Investor Questions End Of Cypress-Forest Deal
- Warner Chilcott 2Q Profit Soars On New Products
- Genvec Says New Novartis Deal Could Yield $13M
August 9, 2010
- AstraZeneca Announces Agreements in Principle in Seroquel Product Liability Litigation
- iReminder Calls for Greater Automation of Risk Evaluation and Mitigation Strategies (REMS) Programs
- King Pharmaceuticals Reports Second-Quarter 2010 Financial Results
- Effectiveness of Statins Is Called Into Question
- Arsenal Of Antibiotics Not Being Restocked
- Drug Stocks Could End Up Being Right Prescription for Portfolio
- King 2Q Profit Plunges On Generic Skelaxin Sales
- Former CEO Of Abbott Laboratories Dies
- DUSA Skin Cancer Therapy Won't Get FDA Incentives
- Arena Pharma Confirms Obesity Drug Review Date
- Isis Takes Larger 2Q Loss On As Spending Rises
- Endo Pharmaceuticals Agrees to Acquire Penwest Pharmaceuticals and Submits NDA For New Formulation of Long-Acting Oxymorphone Designed to be Crush-Resistant
August 10, 2010
- Teva Completes Acquisition of ratiopharm
- Sanofi-aventis Establishes Research Alliance with Scripps Genomic Medicine
- Elan Provides Update on Initiatives to Further Enhance Balance Sheet and Operating Performance
- Inhibitex Posts Wider 2Q Loss On Research Costs
August 11, 2010
- Merck is Rebuying Drug Ingredient Factory in Central Pa. from Contract Manufacturer
- Amarin Says It's Close To Filing For New Heart Drug
- Merck is Rebuying Drug Ingredient Factory in Central Pa. from Contract Manufacturer
- Shire Agrees to Divest Daytrana (Methylphenidate Transdermal System) CII to Noven Pharmaceuticals, Inc.; Shire's 2010 Earnings Outlook Unchanged
- Use of Certain Drugs to Treat Osteoporosis not Associated With Increased Risk of Esophageal or Gastric Cancer
- Eli Lilly Offers Update On Job Cuts
August 12, 2010
- FDA Panel Vouches For Epilepsy Drug Effectiveness
- Big Pharma Continues Its High Pace Of Layoffs
- FDA Panel Vouches For Epilepsy Drug Effectiveness
- Ranbaxy Chief Steps Down, Quarterly Profit Falls
- Ombudsman Welcomes Release Of Adverse Reaction Reports By the European Medicines Agency
- Pharmalive.Com Releases Annual Top 50 Biotechnology Companies Special Report With Analysis Of Corporate Strategies And Pipelines
- FDA: Aseptic Meningitis Risk with Use of Seizure Drug Lamictal
August 13, 2010
- Pharmaceutical Companies in Four States Developing Most of Today's New Mental Illness Drugs
- PDL BioPharma Receives Letter from Genentech Relating to European Patents
- U.S. District Court Rules Against Lilly Regarding Strattera Patent
- FDA Warns of Rare Brain Inflammation With Glaxo's Lamictal
- 'Don't Blame Superbug On India, It's Everywhere'
- Patent Loss On Lilly's Strattera Drug Is Hard To Swallow
August 16, 2010
- Diverse Groups Backing Tox21 Cause
- Black AIDS Institute, in Partnership with Merck, Launches Dynamic National HIV/AIDS Treatment and Care Advocacy Network
- Acquisition of Sigma Pharmaceuticals Limited by Aspen
- Global Vaccine Market Exceeds $20 Billion: Kalorama
August 17, 2010
- FTC: Novartis Must Divest Eye Care Drug
- Alcon Independent Director Committee Notes Results of Shareholder Vote
- Alcon Says 5 Conditionally Elected To Board
- Protalix, Pfizer In $30m Latin America Deal
- Mannkind to Lend 8M Shares to Help Get Financing
- Virtual Biotech a Viable Option In Tough Economy
- Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials
- Eli Lilly Stops Testing of Alzheimer's Drug
- Shire plc - Statement re ProAmatine
August 18, 2010
- Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
- Lilly Pursues OK for Cymbalta for Chronic Pain
- Quark In Novartis Deal And Plans TASE IPO
- MEDIA ADVISORY: Pittsburgh Startup, Knopp Neurosciences, Secures $345 million Licensing Transaction
- Biogen Idec Licenses Lou Gehrig's Disease Drug
- Amarin Names New President/CEO
- Lilly CEO Vows Medical Innovations In Full-Page Ad
August 19, 2010
- FDA Worries About Abuse With Jazz Fibromyalgia Drug
- Philadelphia Jury Clears Prempro in Two Breast-Cancer Cases
- J&J, Stung By Consumer Product Recalls, Creates Quality-Control Position
- Bristol-Myers Cancer Drug Gets Faster FDA Review
- SDI Reports: Novartis Sales Calls to Healthcare Providers Climb 7% in First Half of 2010
August 20, 2010
- Gilead Competitor Applies to Make Generic Hepsera
- Judge Recommends Watson CEO Testify In FTC Probe
- Hospira Announces CEO Succession Plan
- Impax Laboratories Confirms Patent Challenge Relating to Vytorin, 10 mg/80 mg
August 23, 2010
- FDA Drug Safety Communication: Ongoing Safety Review of Stalevo and Possible Increased Cardiovascular Risk
- Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote Supplemental New Drug Application
- Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem 10 mcg
- By 2012, the Global Vaccine Market is Expected to Achieve $34 Billion in Sales: PharmaLive Special Reports
August 24, 2010
- Laid-Off Pfizer Employee Who Stabbed Wife Is Sentenced to State Psychiatric Hospital
- Pfizer's Sutent Fails in Lung Cancer Study
- Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA?
- Roche and Aileron Enter Multi-target Alliance to Develop Stapled Peptide Drugs for Diseases across Multiple Therapeutic Areas
- Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
- Genzyme Seeks at Least $75 per Share From Sanofi-Aventis
- NICE: Colorectal cancer (metastatic) - bevacizumab: Evidence Review Group Response
August 25, 2010
- Inspire Announces Amendment to Ophthalmic Collaboration
- Somaxon Pharmaceuticals Announces Silenor Co-Promotion Agreement with Procter & Gamble
- Study Compares Risk With Two Diabetes Drugs
- Consumers Say Big Pharma Influence On Docs Is Concerning
- Abbott, Skyepharma Part Ways On Asthma Drug Flutiform
August 26, 2010
- Pfizer, Bristol-Myers to Present Apixaban Data
- Alcon Independent Director Committee Notes Closing of Novartis' Acquisition of Nestlé's Stake in Alcon
- Penn Study Makes Breakthrough In Shrinking Tumors of Terminal Melanoma Patients
- District Court Denies sanofi-aventis Request for Preliminary Injunction for Generic Lovenox
- Judge Denies Request To Suspend Generic Lovenox
- Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
- Connecticut Attorney General, DCP Issue Subpoena Regarding Price Increases, Changes In Rite Aid Drug Discount Program
- 4 out of 5 Physicians Online Visited Health Care Professional Sites in Q1 2010
August 27, 2010
- FDA Denies Accelerated Approval For Cancer Drug
- Biotechs Watching Sanofi Bid
- XenoPort Announces Changes to Executive Team
- European Medicines Agency starts review of Pandemrix
- Europe Probes Swine Flu Shot, Narcolepsy Link
- Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment
August 30, 2010
- Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
- AstraZeneca Says Blood Thinner Met Key Study Goals
- Genzyme Confirms Receipt of Unsolicited Proposal
- King Pharmaceuticals Appoints Jeffrey Bailey Chief Commercial Officer
August 31, 2010
- GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
- Online Health Advertisements Increasingly Trusted, Effective, 2010 About.com Health Study Finds
- FDA Sends Sun Warning Letter Over Plant Conditions
- Sun Pharma subsidiary receives warning letter from USFDA
- FDA Issues Warning to Baxter Over Drug Promotion
- Kentucky Attorney General Conway Announces $3.7 Million Settlement with Drug Company
